Pharma fail: Concordia pulls bond as M&A flounders
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
LevFinLevFin Leveraged Loans

Pharma fail: Concordia pulls bond as M&A flounders

Max Bower
October 15, 2015 07:45 PM
Pills_230px

With pharma firms under intense scrutiny in the US, Concordia Healthcare Corp has dropped a planned $950m bond for its $3.5bn acquisition of Amdipharm Mercury, as the debt financing encountered some resistance from investors. Max Bower reports.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansNews contentLoans and High YieldLevFinLeveraged LoansLevFin Leveraged LoansGoldman Sachs
MB
Max Bower
Gift this article